Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report)’s stock price shot up 0.4% during trading on Thursday . The stock traded as high as $591.58 and last traded at $592.06. 237,785 shares traded hands during trading, a decline of 86% from the average session volume of 1,737,968 shares. The stock had previously closed at $589.61.
Wall Street Analysts Forecast Growth
Several brokerages have recently issued reports on ISRG. Raymond James upped their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Barclays upped their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Jefferies Financial Group upped their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. CICC Research began coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price on the stock. Finally, Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $613.10.
Check Out Our Latest Stock Report on Intuitive Surgical
Intuitive Surgical Stock Up 0.1 %
Insider Buying and Selling at Intuitive Surgical
In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of the stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Jamie Samath sold 188 shares of the firm’s stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $101,332.00. Following the completion of the sale, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,720,023. This trade represents a 2.10 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 6,348 shares of company stock worth $3,587,582 over the last 90 days. 0.90% of the stock is owned by insiders.
Institutional Investors Weigh In On Intuitive Surgical
Several institutional investors have recently made changes to their positions in the company. Next Century Growth Investors LLC lifted its holdings in shares of Intuitive Surgical by 72.4% in the 4th quarter. Next Century Growth Investors LLC now owns 6,890 shares of the medical equipment provider’s stock worth $3,596,000 after acquiring an additional 2,893 shares during the last quarter. Ceeto Capital Group LLC purchased a new position in Intuitive Surgical in the 4th quarter worth about $163,000. Petros Family Wealth LLC purchased a new position in Intuitive Surgical in the 4th quarter worth about $1,081,000. Sterling Capital Management LLC increased its stake in Intuitive Surgical by 4.4% in the 4th quarter. Sterling Capital Management LLC now owns 18,577 shares of the medical equipment provider’s stock worth $9,696,000 after buying an additional 790 shares during the period. Finally, Concorde Asset Management LLC increased its stake in Intuitive Surgical by 21.2% in the 4th quarter. Concorde Asset Management LLC now owns 554 shares of the medical equipment provider’s stock worth $289,000 after buying an additional 97 shares during the period. Institutional investors own 83.64% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.